|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008059,
umls-concept:C0009429,
umls-concept:C0019704,
umls-concept:C0028621,
umls-concept:C0237967,
umls-concept:C0243077,
umls-concept:C0525005,
umls-concept:C0556895,
umls-concept:C0674428,
umls-concept:C0871489,
umls-concept:C1318970
|
|
pubmed:issue |
25
|
|
pubmed:dateCreated |
1999-12-21
|
|
pubmed:abstractText |
Consistent long-term viral suppression has been difficult to achieve in children with human immunodeficiency virus type 1 (HIV-1) infection. We tested the safety and antiviral efficacy of a novel combination consisting of efavirenz, nelfinavir, and one or more nucleoside reverse-transcriptase inhibitors in 57 children previously treated with only nucleoside reverse-transcriptase inhibitors.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0028-4793
|
|
pubmed:author |
pubmed-author:BeckerMM,
pubmed-author:BrundageR CRC,
pubmed-author:DanknerW MWM,
pubmed-author:FentonTT,
pubmed-author:FiskeWW,
pubmed-author:FletcherC VCV,
pubmed-author:FlynnP MPM,
pubmed-author:GerstenMM,
pubmed-author:GrahamBB,
pubmed-author:KornhauserD MDM,
pubmed-author:LischnerH WHW,
pubmed-author:ManionDD,
pubmed-author:McNamaraJJ,
pubmed-author:MofensonL MLM,
pubmed-author:PurdueLL,
pubmed-author:RuizNN,
pubmed-author:SiminskiSS,
pubmed-author:SpectorS ASA,
pubmed-author:StarrS ESE,
pubmed-author:VincentCC,
pubmed-author:ZangW JWJ
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
16
|
|
pubmed:volume |
341
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1874-81
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10601506-Adolescent,
pubmed-meshheading:10601506-Benzoxazines,
pubmed-meshheading:10601506-CD4 Lymphocyte Count,
pubmed-meshheading:10601506-Child,
pubmed-meshheading:10601506-Child, Preschool,
pubmed-meshheading:10601506-Drug Therapy, Combination,
pubmed-meshheading:10601506-Female,
pubmed-meshheading:10601506-HIV Infections,
pubmed-meshheading:10601506-HIV Protease Inhibitors,
pubmed-meshheading:10601506-HIV-1,
pubmed-meshheading:10601506-Humans,
pubmed-meshheading:10601506-Male,
pubmed-meshheading:10601506-Nelfinavir,
pubmed-meshheading:10601506-Oxazines,
pubmed-meshheading:10601506-RNA, Viral,
pubmed-meshheading:10601506-Reverse Transcriptase Inhibitors
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team.
|
|
pubmed:affiliation |
Division of Immunologic and Infectious Diseases, Children's Hospital of Philadelphia, PA 19104, USA. starr@email.chop.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
